期刊
BULLETIN OF THE WORLD HEALTH ORGANIZATION
卷 84, 期 8, 页码 613-619出版社
WORLD HEALTH ORGANIZATION
DOI: 10.2471/BLT.05.28696
关键词
-
资金
- Medical Research Council [MC_U190081961] Funding Source: Medline
- Wellcome Trust Funding Source: Medline
- MRC [MC_U190081961] Funding Source: UKRI
- Medical Research Council [MC_U190081961] Funding Source: researchfish
Trachoma is a neglected disease and also the world's leading infectious cause of blindness. It causes misery, dependency and is a barrier to development. Trachoma is controlled by a WHO-endorsed integrated strategy of surgery for trichiasis, antibiotic therapy, facial cleanliness and environmental improvement, which is known by the acronym SAFE. The strategy is based on evidence from field trials and is continually being refined by operational research that informs national policy and planning; the strategy has affected both programme delivery and implementation. As a result of the findings of operational research, surgery is now frequently conducted by paramedics in communities rather than by ophthalmologists in hospitals; yearly mass distribution of a single oral dose of azithromycin has replaced the use of topical tetracycline; and the promotion of better hygiene, face-washing and the use of latrines are used to reduce transmission. Those who implement programmes have been equal partners in conducting operational research thus reducing the know-do gap and minimizing the lag that often exists between the completion of trials and putting their results into practice. Operational research has become a part of practice. Although there are still many questions without answers, national programme coordinators have a reasonable expectation that trachoma control programmes based on SAFE will work.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据